{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:43:10Z","timestamp":1791240190429,"version":"4.1.0"},"reference-count":41,"publisher":"Bentham Science Publishers Ltd.","issue":"12","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2020,12,2]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>This article reviews the role of INSL3 as biomarker of Leydig cell function and its\nsystemic action in testis-bone-skeletal muscle crosstalk in adult men. Insulin-like factor 3 (INSL3)\nis a peptide hormone secreted constitutively in a differentiation-dependent mode by testicular\nLeydig cells. Besides the role for the testicular descent, this hormone has endocrine anabolic functions\non the bone-skeletal muscle unit. INSL3 levels are low in many conditions of undifferentiated\nor altered Leydig cell status, however the potential clinical utility of INSL3 measurement is not yet\nwell defined. INSL3 levels are modulated by the long-term cytotropic effect of the hypothalamicpituitary-\ngonadal axis, unlike testosterone that is acutely sensitive to the stimulus by luteinizing\nhormone (LH). INSL3 directly depends on the number and differentiation state of Leydig cells and\ntherefore it represents the ideal marker of Leydig cell function. This hormone is more sensitive\nthan testosterone to Leydig cell impairment, and the reduction of INSL3 in adult men can precociously\ndetect an endocrine testicular dysfunction. Low INSL3 levels could cause or contribute to\nsome symptoms and signs of male hypogonadism, above all sarcopenia and osteoporosis. The measurement\nprovided suggested that the measurement of INSL3 levels should be considered in the\nclinical management of male hypogonadism and in the evaluation of testicular endocrine function.\nThe monitoring of INSL3 levels could allow an early detection of Leydig cell damage, even when\ntestosterone levels are still in the normal range.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929866527666200925105739","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T05:50:28Z","timestamp":1601272228000},"page":"1246-1252","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["INSL3: A Marker of Leydig Cell Function and Testis-Bone-Skeletal Muscle Network"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9257-1043","authenticated-orcid":true,"given":"Paolo","family":"Facondo","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Unit of Endocrinology and Metabolism, University of Brescia, ASST Spedali Civili Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7474-3451","authenticated-orcid":true,"given":"Andrea","family":"Delbarba","sequence":"additional","affiliation":[{"name":"Department of Medicine, Unit of Endocrinology and Metabolism, ASST Spedali Civili Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-1294","authenticated-orcid":true,"given":"Filippo","family":"Maffezzoni","sequence":"additional","affiliation":[{"name":"Department of Medicine, Unit of Endocrinology and Metabolism, ASST Spedali Civili Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-1232","authenticated-orcid":true,"given":"Carlo","family":"Cappelli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Unit of Endocrinology and Metabolism, University of Brescia, ASST Spedali Civili Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5817-8141","authenticated-orcid":true,"given":"Alberto","family":"Ferlin","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, Unit of Endocrinology and Metabolism, University of Brescia, ASST Spedali Civili Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1095\/biolreprod.113.108969","volume":"88","author":"Ivell R.","year":"2013","unstructured":"Ivell R.; Wade J.D.; Anand-Ivell R.; INSL3 as a biomarker of leydig cell functionality. Minireview. Biol Reprod 2013,88(6),1-8","journal-title":"Biol Reprod"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2605.2010.01074.x","volume":"34","author":"Bay K.","year":"2011","unstructured":"Bay K.; Andersson A.M.; Human testicular insulin-like factor 3: In relation to development, reproductive hormones and andrological disorders. Int J Androl 2011,34(2),97-109","journal-title":"Int J Androl"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.1210\/jc.2004-0575","volume":"89","author":"Foresta C.","year":"2004","unstructured":"Foresta C.; Bettella A.; Vinanzi C.; Dabrilli P.; Meriggiola M.C.; Garolla A.; Ferlin A.; A novel circulating hormone of testis origin in humans. J Clin Endocrinol Metab 2004,89(12),5952-5958","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/andr.12597","volume":"7","author":"Sansone A.","year":"2019","unstructured":"Sansone A.; Kliesch S.; Isidori A.M.; Schlatt S.; AMH and INSL3 in testicular and extragonadal pathophysiology: What do we know? Andrology 2019,7(2),131-138","journal-title":"Andrology"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1210\/jc.2007-1690","volume":"92","author":"O\u2019Shaughnessy P.J.","year":"2007","unstructured":"O\u2019Shaughnessy P.J.; Baker P.J.; Monteiro A.; Cassie S.; Bhattacharya S.; Fowler P.A.; Developmental changes in human fetal testicular cell numbers and messenger ribonucleic acid levels during the second trimester. J Clin Endocrinol Metab 2007,92(12),4792-4801","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3389\/fendo.2019.00596","volume":"10","author":"Harrison S.M.","year":"2019","unstructured":"Harrison S.M.; Bush N.C.; Wang Y.; Mucher Z.R.; Lorenzo A.J.; Grimsby G.M.; Schlomer B.J.; B\u00fcllesbach E.E.; Baker L.A.; Insulin-Like Peptide 3 (INSL3) serum concentration during human male fetal life. Front Endocrinol (Lausanne) 2019,10,596","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/humrep\/den038","volume":"23","author":"Anand-Ivell R.","year":"2008","unstructured":"Anand-Ivell R.; Ivell R.; Driscoll D.; Manson J.; Insulin-like factor 3 levels in amniotic fluid of human male fetuses. Hum Reprod 2008,23(5),1180-1186","journal-title":"Hum Reprod"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1210\/jc.2006-0821","volume":"91","author":"Ferlin A.","year":"2006","unstructured":"Ferlin A.; Garolla A.; Rigon F.; Rasi Caldogno L.; Lenzi A.; Foresta C.; Changes in serum insulin-like factor 3 during normal male puberty. J Clin Endocrinol Metab 2006,91(9),3426-3431","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2605.2006.00714.x","volume":"29","author":"Anand-Ivell R.","year":"2006","unstructured":"Anand-Ivell R.; Wohlgemuth J.; Haren M.T.; Hope P.J.; Hatzinikolas G.; Wittert G.; Ivell R.; Peripheral INSL3 concentrations decline with age in a large population of Australian men. Int J Androl 2006,29(6),618-626","journal-title":"Int J Androl"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MED.0b013e3283453fe6","volume":"18","author":"Ivell R.","year":"2011","unstructured":"Ivell R.; Anand-Ivell R.; Biological role and clinical significance of insulin-like peptide 3. Curr Opin Endocrinol Diabetes Obes 2011,18(3),210-216","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1095\/biolreprod.105.048165","volume":"74","author":"Anand-Ivell R.J.","year":"2006","unstructured":"Anand-Ivell R.J.; Relan V.; Balvers M.; Coiffec-Dorval I.; Fritsch M.; Bathgate R.A.; Ivell R.; Expression of the insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis. Biol Reprod 2006,74(5),945-953","journal-title":"Biol Reprod"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"7323","DOI":"10.1073\/pnas.0307061101","volume":"101","author":"Kawamura K.","year":"2004","unstructured":"Kawamura K.; Kumagai J.; Sudo S.; Chun S.Y.; Pisarska M.; Morita H.; Toppari J.; Fu P.; Wade J.D.; Bathgate R.A.; Hsueh A.J.; Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc Natl Acad Sci USA 2004,101(19),7323-7328","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"13068","DOI":"10.1074\/jbc.M600472200","volume":"281","author":"Del Borgo M.P.","year":"2006","unstructured":"Del Borgo M.P.; Hughes R.A.; Bathgate R.A.; Lin F.; Kawamura K.; Wade J.D.; Analogs of insulin-like peptide 3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivo. J Biol Chem 2006,281(19),13068-13074","journal-title":"J Biol Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e13715","DOI":"10.1111\/ and.13715","volume":"59","author":"Shokri S.","year":"2020","unstructured":"Shokri S.; Tavalaee M.; Ebrahimi S.M.; Ziaeipour S.; Nasr-Esfahani M.H.; Nejatbakhsh R.; Expression of RXFP2 receptor on human spermatozoa and the anti-apoptotic and antioxidant effects of insulin-like factor 3. Andrologia 2020,59(9),e13715","journal-title":"Andrologia"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mce.2018.12.021","volume":"487","author":"De Toni L.","year":"2019","unstructured":"De Toni L.; Agoulnik A.I.; Sandri M.; Foresta C.; Ferlin A.; INSL3 in the muscolo-skeletal system. Mol Cell Endocrinol 2019,487,12-17","journal-title":"Mol Cell Endocrinol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nrendo.2013.135","volume":"9","author":"Ferlin A.","year":"2013","unstructured":"Ferlin A.; Selice R.; Carraro U.; Foresta C.; Testicular function and bone metabolism-beyond testosterone. Nat Rev Endocrinol 2013,9(9),548-554","journal-title":"Nat Rev Endocrinol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1677\/joe.1.06697","volume":"189","author":"Fu P.","year":"2006","unstructured":"Fu P.; Shen P.J.; Zhao C.X.; Scott D.J.; Samuel C.S.; Wade J.D.; Tregear G.W.; Bathgate R.A.D.; Gundlach A.L.; Leucine-rich repeat-containing G-protein-coupled receptor 8 in mature glomeruli of developing and adult rat kidney and inhibition by insulin-like peptide-3 of glomerular cell proliferation. J Endocrinol 2006,189(2),397-408","journal-title":"J Endocrinol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neuroscience.2008.07.029","volume":"156","author":"Sedaghat K.","year":"2008","unstructured":"Sedaghat K.; Shen P.J.; Finkelstein D.I.; Henderson J.M.; Gundlach A.L.; Leucine-rich repeat-containing G-protein-coupled receptor 8 in the rat brain: Enrichment in thalamic neurons and their efferent projections. Neuroscience 2008,156(2),319-333","journal-title":"Neuroscience"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/ijc.25068","volume":"127","author":"Hombach-Klonisch S.","year":"2010","unstructured":"Hombach-Klonisch S.; Bialek J.; Radestock Y.; Truong A.; Agoulnik A.I.; Fiebig B.; Willing C.; Weber E.; Hoang-Vu C.; Klonisch T.; INSL3 has tumor-promoting activity in thyroid cancer. Int J Cancer 2010,127(3),521-531","journal-title":"Int J Cancer"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3389\/fendo.2019.00906","volume":"10","author":"Rodprasert W.","year":"2020","unstructured":"Rodprasert W.; Virtanen H.E.; M\u00e4kel\u00e4 J.A.; Toppari J.; Hypogonadism and cryptorchidism. Front Endocrinol 2020,10,906","journal-title":"Front Endocrinol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/humrep\/deu124","volume":"29","author":"Lottrup G.","year":"2014","unstructured":"Lottrup G.; Nielsen J.E.; Maroun L.L.; M\u00f8ller L.M.A.; Yassin M.; Leffers H.; Skakkeb\u00e6k N.E.; Rajpert-De Meyts E.; Expression patterns of DLK1 and INSL3 identify stages of Leydig cell differentiation during normal development and in testicular pathologies, including testicular cancer and Klinefelter syndrome. Hum Reprod 2014,29(8),1637-1650","journal-title":"Hum Reprod"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/andr.12581","volume":"7","author":"Steggink L.C.","year":"2019","unstructured":"Steggink L.C.; van Beek A.P.; Boer H.; Meijer C.; Lubberts S.; Oosting S.F.; de Jong I.J.; van Ginkel R.J.; Lefrandt J.D.; Gietema J.A.; Nuver J.; Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: Effects of \u03b2-hCG and cancer treatment. Andrology 2019,7(4),441-448","journal-title":"Andrology"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.2047-2927.2014.00204.x","volume":"2","author":"Overvad S.","year":"2014","unstructured":"Overvad S.; Bay K.; Bojesen A.; Gravholt C.H.; Low INSL3 in Klinefelter syndrome is related to osteocalcin, testosterone treatment and body composition, as well as measures of the hypothalamic-pituitary-gonadal axis. Andrology 2014,2(3),421-427","journal-title":"Andrology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000479572","volume":"12","author":"Freire A.V.","year":"2018","unstructured":"Freire A.V.; Grinspon R.P.; Rey R.A.; Importance of serum testicular protein hormone measurement in the assessment of disorders of sex development. Sex Dev 2018,12(1-3),30-40","journal-title":"Sex Dev"},{"key":"ref=25","first-page":"548","volume":"72","author":"Chong Y.H.","year":"2017","unstructured":"Chong Y.H.; Pankhurst M.W.; McLennan I.S.; The testicular hormones AMH, InhB, INSL3, and testosterone can be independently deficient in older men. J Gerontol A Biol Sci Med Sci 2017,72(4),548-553","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1365-2265.2009.03549.x","volume":"71","author":"Foresta C.","year":"2009","unstructured":"Foresta C.; Di Mambro A.; Pagano C.; Garolla A.; Vettor R.; Ferlin A.; Insulin-like factor 3 as a marker of testicular function in obese men. Clin Endocrinol (Oxf) 2009,71(5),722-726","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1530\/EJE-09-0203","volume":"161","author":"Ermetici F.","year":"2009","unstructured":"Ermetici F.; Donadio F.; Iorio L.; Malavazos A.E.; Dolci A.; Peverelli E.; Barbieri A.M.; Morricone L.; Chiodini I.; Arosio M.; Lania A.; Beck-Peccoz P.; Ambrosi B.; Corbetta S.; Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: Effect of glycemic control and visceral adiposity on Leydig cell function. Eur J Endocrinol 2009,161(6),853-859","journal-title":"Eur J Endocrinol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1530\/REP-13-0486","volume":"147","author":"Anand-Ivell R.","year":"2014","unstructured":"Anand-Ivell R.; Ivell R.; Insulin-like factor 3 as a monitor of endocrine disruption. Reproduction 2014,147(4),R87-R95","journal-title":"Reproduction"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1289\/ehp.1409288","volume":"124","author":"Toft G.","year":"2016","unstructured":"Toft G.; J\u00f6nsson B.A.; Bonde J.P.; N\u00f8rgaard-Pedersen B.; Hougaard D.M.; Cohen A.; Lindh C.H.; Ivell R.; Anand-Ivell R.; Lindhard M.S.; Perfluorooctane sulfonate concentrations in amniotic fluid, biomarkers of fetal Leydig cell function, and cryptorchidism and hypospadias in Danish boys (1980\u20131996). Environ Health Perspect 2016,124(1),151-156","journal-title":"Environ Health Perspect"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.jpedsurg.2017.03.064","volume":"52","author":"van Brakel J.","year":"2017","unstructured":"van Brakel J.; de Muinck Keizer-Schrama S.M.P.F.; Hazebroek F.W.J.; Dohle G.R.; de Jong F.H.; INSL3 and AMH in patients with previously congenital or acquired undescended testes. J Pediatr Surg 2017,52(8),1327-1331","journal-title":"J Pediatr Surg"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12851","author":"Santi D.","year":"2020","unstructured":"Santi D.; Ivell R.; Anand-Ivell R.; De Toni L.; Fanelli F.; Mezzullo M.; Pelusi C.; Pagotto U.; Belli S.; Granata A.R.M.; Roli L.; Rochira V.; Trenti T.; Ferlin A.; Simoni M.; Effects of acute hCG stimulation on serum INSL3 and 25-OH vitamin D in Klinefelter syndrome. Andrology Online ahead of print2020","journal-title":"Andrology"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"e29733","DOI":"10.1371\/journal.pone.0029733","volume":"6","author":"Ferlin A.","year":"2011","unstructured":"Ferlin A.; Perilli L.; Gianesello L.; Taglialavoro G.; Foresta C.; Profiling Insulin Like Factor 3 (INSL3) signaling in human osteoblasts. PLoS One 2011,6(12),e29733","journal-title":"PLoS One"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1210\/jc.2017-02762","volume":"103","author":"Di Nisio A.","year":"2018","unstructured":"Di Nisio A.; De Toni L.; Rocca M.S.; Ghezzi M.; Selice R.; Taglialavoro G.; Ferlin A.; Foresta C.; Negative association between sclerostin and INSL3 in isolated human osteocytes and in klinefelter syndrome: New hints for testis-bone crosstalk. J Clin Endocrinol Metab 2018,103(5),2033-2041","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1210\/en.2007-0270","volume":"148","author":"Baron R.","year":"2007","unstructured":"Baron R.; Rawadi G.; Targeting the Wnt\/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 2007,148(6),2635-2643","journal-title":"Endocrinology"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1359\/jbmr.080204","volume":"23","author":"Ferlin A.","year":"2008","unstructured":"Ferlin A.; Pepe A.; Gianesello L.; Garolla A.; Feng S.; Giannini S.; Zaccolo M.; Facciolli A.; Morello R.; Agoulnik A.I.; Foresta C.; Mutations in the insulin-like factor 3 receptor are associated with osteoporosis. J Bone Miner Res 2008,23(5),683-693","journal-title":"J Bone Miner Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.nmd.2019.11.006","volume":"30","author":"Passeri E.","year":"2020","unstructured":"Passeri E.; Sansone V.A.; Sconfienza L.M.; Messina C.; Meola G.; Corbetta S.; Fragility fractures and bone mineral density in male patients affected by type 1 and type 2 myotonic dystrophy. Neuromuscul Disord 2020,30(1),28-34","journal-title":"Neuromuscul Disord"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1041760","DOI":"10.1155\/2019\/1041760","volume":"2019","author":"Coskun G.","year":"2019","unstructured":"Coskun G.; Sencar L.; Tuli A.; Saker D.; Alparslan M.M.; Polat S.; Effects of osteocalcin on synthesis of testosterone and INSL3 during adult leydig cell differentiation. Int J Endocrinol 2019,2019,1041760","journal-title":"Int J Endocrinol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3389\/fendo.2018.00562","volume":"9","author":"Ferlin A.","year":"2018","unstructured":"Ferlin A.; De Toni L.; Agoulnik A.I.; Lunardon G.; Armani A.; Bortolanza S.; Blaauw B.; Sandri M.; Foresta C.; Protective role of testicular hormone INSL3 from atrophy and weakness in skeletal muscle. Front Endocrinol (Lausanne) 2018,9,562","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2018-00229","volume":"103","author":"Bhasin S.","year":"2018","unstructured":"Bhasin S.; Brito J.P.; Cunningham G.R.; Hayes F.J.; Hodis H.N.; Matsumoto A.M.; Snyder P.J.; Swerdloff R.S.; Wu F.C.; Yialamas M.A.; Testosterone therapy in men with hypogonadism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2018,103(5),1715-1744","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"dgaa145","DOI":"10.1210\/clinem\/dgaa145","volume":"105","author":"Albrethsen J.","year":"2020","unstructured":"Albrethsen J.; Johannsen T.H.; J\u00f8rgensen N.; Frederiksen H.; Sennels H.P.; J\u00f8rgensen H.L.; Fahrenkrug J.; Petersen J.H.; Linneberg A.; Nordkap L.; Bang A.K.; Andersson A.M.; Juul A.; Evaluation of serum insulin-like factor 3 quantification by LC-MS\/MS as a biomarker of leydig cell function. J Clin Endocrinol Metab 2020,105(6),dgaa145","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1515\/cclm-2018-0171","volume":"56","author":"Albrethsen J.","year":"2018","unstructured":"Albrethsen J.; Frederiksen H.; Andersson A.M.; Anand-Ivell R.; Nordkap L.; Bang A.K.; J\u00f8rgensen N.; Juul A.; Development and validation of a mass spectrometry-based assay for quantification of insulin-like factor 3 in human serum. Clin Chem Lab Med 2018,56(11),1913-1920","journal-title":"Clin Chem Lab Med"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/186286","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/186286\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/186286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T18:43:50Z","timestamp":1626979430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/186286\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,2]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866527666200925105739","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}